Replies to post #39105 on PharmaCyte Biotech Inc (PMCB)

[rudygerner]

Everything points to a buyout from where I sit. We've now acquired Mr. Liquard(Pfizer) and Dr. Manuel Hidalgo(Dr. Von Hoff protege). We own the rights to the Melligen cells for diabetes and we own the license for Cell-in-a-Box diabetes. Big pharma will purchase PharmaCyte Biotech, imo, but I do think PMCB's diabetes treatment will be the reason why. Their pancreatic cancer/malignant ascites treatment is the shot across the bow, but their diabetes treatment has the capability to produce more future revenue and big pharma is all about forward earnings. Given the current stages of development and legalization, I dunno how to interpret the cannabinoids. But I do know their diabetes treatment is unique - no other diabetes treatment in the world, currently in existence or development, can reverse glucose levels (cure diabetes) without the use of either a device or immunosuppresive drugs - nothing else even comes close to the Melligen cells/CiaB combo. What's that worth? Billions $$$$$$$$$$$$.